{"id":338473,"date":"2026-11-04T11:15:27","date_gmt":"2026-11-04T05:45:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/aarti-drugs-q2-results-fy27-pat-83-crore\/"},"modified":"2026-11-04T11:15:27","modified_gmt":"2026-11-04T05:45:27","slug":"aarti-drugs-q2-results-fy27-pat-83-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aarti-drugs-q2-results-fy27-pat-83-crore\/","title":{"rendered":"Aarti Drugs Q2 Results FY27: PAT Jumps 83.28% To Rs 82.77 Cr, Revenue Rs 826.24 Cr, PAT Rs 82.77 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Aarti Drugs Q2 Results FY27 were declared on 3 November 2026 on a Consolidated basis. Revenue climbed 26.57% to Rs 826.24 Cr from Rs 652.79 Cr, and net profit climbed 83.28% to Rs 82.77 Cr from Rs 45.16 Cr. These quarterly results show YoY growth on every reported line, with profit expanding much faster than sales.<\/p>\n<\/div>\n

Aarti Drugs Ltd (AARTIDRUGS) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. The results date is 3 November, and the numbers are consolidated results: revenue of Rs 826.24 Cr and net profit of Rs 82.77 Cr. Aarti Drugs Q2 Results FY27 also report Operating Profit of Rs 135.36 Cr, up from Rs 84.28 Cr.<\/p>\n

Readers of this Aarti Drugs Q2 Results results analysis will find the financial highlights, the disclosed business drivers, the FY27 outlook and the risks in one place, built from figures Univest compiled for the quarter. The Financial Highlights table sits directly below, so the results analysis can start from the reported numbers.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n